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Neurons in the hippocampal CA1 region are particularly sensitive to oxidative stress (OS), whereas those in CA3 are resistant. To uncover
mechanisms for selective CA1 vulnerability to OS, we treated organotypic hippocampal slices with duroquinone and compared transcriptional
profiles of CA1 vs CA3 cells at various intervals. Gene Ontology and Biological Pathway analyses of differentially expressed genes showed that at
all time points, CA1 had higher transcriptional activity for stress/inflammatory response, transition metal transport, ferroxidase, and presynaptic
signaling activity, while CA3 had higher GABA-signaling, postsynaptic, and calcium and potassium channel activity. Real-time PCR and
immunoblots confirmed the transcriptome data and the induction of OS by duroquinone in both hippocampal regions. Our functional genomics
approach has identified in CA1 cells molecular pathways as well as unique genes, such as guanosine deaminase, lipocalin 2, synaptotagmin 4, and
latrophilin 2, whose time-dependent induction following the initiation of OS may represent attempts at neurite outgrowth, synaptic recovery, and
resistance against OS.
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generation and scavenging of reactive oxygen (ROS) and
nitrogen species, can lead to cell damage during aging and to
age-associated neurodegenerative diseases [1–3]. Neurons in
the central nervous system demonstrate different levels of
sensitivity to OS, with some neuronal populations being very
sensitive and others quite resistant. A good example of
differential neuronal vulnerability is found in the hippocampus,
a brain structure involved in learning and memory processes.
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⁎ Corresponding author. Department of Pharmacology and Toxicology,
University of Kansas, Lawrence, KS 66045, USA. Fax: +1 785 864 5219.
E-mail address: emichaelis@ku.edu (E.K. Michaelis).
0888-7543/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.ygeno.2007.03.007vulnerable to OS, while those in the adjacent CA3 region are
resistant [4,5]. CA1 neurons are also vulnerable to other adverse
conditions, including epileptic seizures [6] and hypoxia- or
ischemia-induced neuronal damage [7,8]. Since OS is associated
with these adverse conditions, it is quite possible that the
sensitivity of CA1 neurons to these seemingly different
conditions is due to a shared commonality, i.e., sensitivity to
OS. There is little information on the underlying mechanisms of
selective neuronal vulnerability. Therefore, the study of mo-
lecular mechanisms that may determine selective vulnerability
to OS may provide important information on the molecular
determinants of neuronal sensitivity to various types of brain
insult.
There have been few attempts to elucidate the molecular
underpinnings of the differential sensitivity of CA1 neurons to
OS. In a previous study, we probed the expression of known pro-
oxidant and antioxidant genes in CA1 and CA3 regions of
unstimulated, nonstressed hippocampal slices maintained in
Fig. 1. (A) Differential, time-dependent cell death in CA1 and CA3 neurons
following duroquinone (DQ) treatment and (B) the outline of the treatment
procedure selected for the comparative mRNA and protein studies. The cell death
data shown in (A) were obtained using the PI assay as described under
Experimental methods. The data represent the mean (±SEM) percentage of lost
cells from the examination of six brain slices per time interval of exposure to DQ.
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neurons exhibit high intrinsic oxidative activity even in the
absence of exogenous stimuli and we proposed that this property
of CA1 neurons may be responsible for their selective vul-
nerability to OS [4]. Other investigators have also attempted to
determine differences in transcriptional patterns among the
various regions of the hippocampus under normal conditions
[9–13]. However, none of these studies was designed to probe
the dynamic, time-dependent responses of neurons in CA1 and
CA3 to acute exposure to OS.
In an attempt to shed more light on the molecular mech-
anisms of CA1 vulnerability to OS, we conducted dynamic
genome-wide transcriptional analyses on the response of CA1
and CA3 neurons to in vitro-applied OS. Four time points
representing different periods of exposure to OS and of post-
OS recovery were selected to detect differences in dynamic
changes in the induction of gene expression between the two
hippocampal regions. Our hypothesis was that differential
transcriptional responses to OS in CA1 vs CA3 underlies (at
least partially) their opposite fates following such stress.
Results and discussion
Differential vulnerability of CA1 and CA3 neurons to OS
We used organotypic hippocampal slice cultures [14] to
study the differential vulnerability of CA1 and CA3 neurons to
increased OS. Treatment of the cultures with duroquinone (DQ)
was used to generate ROS in cells. DQ elevates superoxide
(O2
U−) levels in cells [15]. Following a relatively quiescent
period between 0 and 3 h of treatment with DQ in terms of cell
death, there was substantial cell loss in CA1, not in CA3, after
removal of DQ and continued incubation in culture medium
(Fig. 1A). Exposure to OS for 3 h caused delayed cell death in
CA1 that occurred at 9 and 21 h post-termination of treatment
with DQ (Fig. 1A). At 21 h following termination of DQ
treatment, 64% of CA1 neurons were dead, whereas only 7% of
CA3 neurons died during the same period. Neuronal death
reached a plateau in both regions after this time post-treatment
with DQ (data not shown). The pattern of neuronal death
shown in Fig. 1 was in agreement with that seen in previous
studies [5].
Based on the results shown in Fig. 1A, we selected four time
points to conduct studies of dynamic changes in gene
expression following induction of OS. DQ treatment of slices
was from 0 to 3 h (Fig. 1B). The time points selected for mRNA
extraction and gene array analyses were 0 h, the basal condition
of neurons just before initiation of DQ treatment; 0.5 h, the early
phase of neuronal response to DQ treatment; 3 h, the end of the
OS treatment; and 12 h, a time point that was 9 h post-
termination of treatment with DQ. The time point of 0.5 h from
initiation of treatment was selected to detect changes in
expression of early stress-response genes. DQ treatment for
0.5 and 3 h did not produce significant cell death in either CA1
or CA3 regions (Fig. 1A), yet was likely to have caused changes
in expression of early stress-response genes. There was, how-
ever, loss of approximately 40% of CA1 neurons by 12 h (9 hpost-treatment with DQ). Because of this cell loss, the
genomic analyses performed on slices at 12 h were likely to
underestimate the magnitude of changes in gene expression
of CA1 neurons. To avoid further confounding of the gene
expression studies by the presence of excessive cell death in
CA1, we did not include the 24-h time point in our gene array
analyses.
Reproducibility of gene array data obtained from treated
hippocampal slices
The microarray data obtained using the treatment protocol
shown in Fig. 1B and Affymetrix GeneChip RAE230A arrays
showed high correlation between replicate samples (n=4) and a
mean correlation coefficient of 0.94 (ranging from 0.91 to
0.97). These results indicated high reproducibility for each
hippocampal region at each time point and across slices
obtained from different animals. The high reproducibility
achieved in this analysis was, at least in part, a reflection of the
homogeneity of the dissected CA1 and CA3 samples used for
the array hybridization. The manual microscopic cell procure-
ment used in the present study was close, in terms of
reproducibility of the generated microarray data, to the laser
capture microdissection method (LCM). In a separate series of
experiments, we used fresh, coronal brain sections using LCM
to collect CA1 and CA3 neurons for microarray analyses
(identical GeneChip used with LCM and hand microdissec-
tion). The mean correlation coefficient between replicates using
LCM was 0.96 (range: 0.91–0.99), i.e., very similar to the
results of hand microdissection.
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both CA1 and CA3 neurons
To identify genes showing significant time-dependent
alterations in expression during and after DQ treatment, we
used a BioConductor package called “Timecourse,” based on
multivariate empirical Bayes statistics [16]. The package ranked
all “present” (i.e., expressed) genes by statistical significance
associated with their time-dependent dynamic changes. Ana-
lyses based on multivariate empirical Bayes statistics have some
advantages over traditional F statistics, such as the incorpora-
tion of correlations among time-course samples, integration of
replicate variances, and integration of information across genes.
Using this type of analysis, probe sets showing significant
responses to DQ treatment in both CA1 and CA3 were
identified. Seventy-seven probe sets whose response patterns
in CA1 and CA3 converged (Pearson’s correlation coefficientFig. 2. Hierarchical clustering of genes with (A) similar or (B, C) divergent transcrip
represent averages of all replicate samples across four time periods and are depicted b
centered to 1.0. (A) Genes with similar patterns of response in CA1 and CA3 and whos
I, those that increased as type II. (B) Clustering of group I, II, and III genes that exhib
expressed more highly in CA1 than in CA3 were labeled as type I, those more hig
differential expression as type II. (C) Enlarged view of type I genes demonstrating t
followed by increased expression during and after DQ (from top:Dcn to Itih3 and the
the remaining genes). *EST, expressed sequence tag (function unknown); **Gda, th>0.75) to the DQ treatment were identified. The 77 probe sets
represented 0.49% of the total 15,866 probe sets on the array. A
hierarchical clustering of all 77 probe sets is shown in Fig. 2A.
There were concordant response patterns of the same genes in
the two hippocampal regions, an indication that CA1 and CA3
shared a certain degree of commonality in terms of the response
to DQ treatment. The currently known genes among the 77
probe sets are listed in Table 1.
Based on the hierarchical clustering shown in Fig. 2A, the
genes were further subdivided into two groups marked as I and
II. The total number of genes in group I was 23. The currently
known genes in this group are listed in Table 1 and represent
genes whose expression was significantly down-regulated in
both CA1 and CA3 following DQ treatment. Down-regulation
of genes such as CD36 (thrombospondin receptor, a class B
scavenger receptor), is assumed to offer protection against DQ-
elicited neuronal damage, because the overexpression of thistional responses to DQ-induced OS in CA1 and CA3. Relative expression levels
y different colors (color bar shown). The mean of all probe sets on the array was
e expression decreased during and following DQ treatment were grouped as type
ited differential expression patterns between CA1 and CA3. Genes consistently
hly in CA3 than in CA1 as type III, and those without a consistent pattern of
wo somewhat different patterns of expression in CA1: low baseline expression
last two genes at bottom) vs high baseline expression that remained high (most of
e same gene as the one above but identified by a different probe set.
Table 1
Currently known genes showing similar expression patterns in CA1 and CA3 in
response to increased OS
Affx_ID Gene
symbol
Description
Genes whose expression was down-regulated following DQ treatment
1368270_at Apobec1 Apolipoprotein B editing complex 1
1373025_at C1qg Complement component 1, q subcomponent,
gamma polypeptide
1389123_at Ccl6 Chemokine (C–C motif) ligand 6
1386901_at Cd36 CD36 antigen
1370891_at Cd48 CD48 antigen
1368518_at Cd53 CD53 antigen
1367776_at Cdc2a Cell division cycle 2 homolog A
1371250_at Cxcl4 Chemokine (C–X–C motif) ligand 4
1398246_s_at Fcgr3 Fc receptor, IgG, low affinity III
1367628_at Lgals1 Lectin, galactose binding, soluble 1
1390510_at Ms4a6b Membrane-spanning 4-domains, subfamily A,
member 6B
1388340_at Ns5atp9 NS5A (hepatitis C virus) transactivated
protein 9
1398540_at Rgs1 Regulator of G-protein signaling 1
1390412_at Slc40a1 Solute carrier family 39
(iron-regulated transporter), member 1
1388809_at Smpdl3a Sphingomyelin phosphodiesterase, acid-like 3A
Genes whose expression was up-regulated following DQ treatment
1369268_at Atf3 Activating transcription factor 3
1370869_at Bcat1 Branched-chain aminotransferase 1, cytosolic
1368677_at Bdnf Brain-derived neurotrophic factor
1398251_a_at Camk2b Calcium/calmodulin-dependent protein
kinase II β subunit
1390566_a_at Ckmt1 Creatine kinase, mitochondrial 1, ubiquitous
1368381_at Crtac1 Cartilage acidic protein 1
1370053_at Dlgap1 Discs, large (Drosophila) homolog-associated
protein 1
1376345_at Drd1ip Dopamine receptor D1-interacting protein
(calcyon)
1372016_at Gadd45b Growth arrest and DNA-damage-inducible 45 beta
1388792_at Gadd45g Growth arrest and DNA-damage-inducible 45
gamma
1387906_a_at Gnas GNAS complex locus
1373202_at Gng3 Guanine nucleotide binding protein (G protein), γ3
1370997_at Homer1 Homer homolog 1 (Drosophila)
1370912_at Hspa1b Heat shock 70-kD protein 1B
1389514_at Lrrn6a Leucine-rich repeat neuronal 6A
1367956_at Ncdn Neurochondrin
1370229_at Ndrg4 N-myc downstream-regulated gene 4
1376362_at Nptxr Neuronal pentraxin receptor
1370211_at Nrgn Neurogranin
1386969_at Nrn1 Neuritin
1368956_at Pcdh8 Protocadherin 8
1367835_at Pcsk1n Proprotein convertase subtilisin/kexin type 1
inhibitor
1368106_at Plk2 Polo-like kinase 2 (Drosophila)
1387929_at Pmf31 PMF32 protein
1389463_at Prkar1b Protein kinase, cAMP-dependent regulatory,
type I, beta
1368505_at Rgs4 Regulator of G-protein signaling 4
1368373_at Rgs7 Regulator of G-protein signaling 7
1368564_at Slc17a6 Solute carrier family 17 (sodium-dependent
inorganic phosphate cotransporter), member 6
1371568_at Sncb Synuclein, β
1389008_at Spred2 Sprouty-related, EVH1-domain containing 2
1370042_at Stmn2 Stathmin-like 2
1368562_at Sult4a1 Sulfotransferase family 4A, member 1
1369977_at Uchl1 Ubiquitin carboxy-terminal hydrolase L1
204 X. Wang et al. / Genomics 90 (2007) 201–212gene is known to increase OS [17]. The CD36 protein is
involved in scavenging by-products of OS in cells [18] and its
expression is increased during β-amyloid deposition [19], a
stimulus of OS in Alzheimer disease.
Of the 54 genes in group II, the currently known ones
are shown in Table 1. The expression of some genes in this
group, such as Hspa1b (heat shock 70-kDa protein 1B), Atf3
(activating transcription factor 3), and Bdnf (brain-derived
neurotrophic factor), was rapidly increased, i.e., within 0.5 h
following the application of OS (Fig. 2A). The rapid up-
regulation of these genes was, probably, a reflection of cellular
attempts at controlling damage. HSP70 is one of the early
responders to stress and is reported to be protective against OS
[20–22]. Atf3 is another immediate early gene responding to a
wide variety of stress conditions, including OS [23]. Bdnf has
also been found to increase quickly after induction of cell stress
and to limit the damaging effects of stress in brain [24]. It is
important to point out also that BDNF released in the vicinity of
neurons leads to the induction of Nrn1 (neuritin) [25], a gene
whose product promotes neurite outgrowth in hippocampal
neurons. Nrn1 expression was significantly increased in both
CA1 and CA3 following induction of OS (Table 1), and the
increased expression of Nrn1 fit with the observed up-
regulation of Bdnf expression. Other stress-inducible genes
whose expression was increased in both CA1 and CA3 were
Gadd45b and Gadd45g (Table 1). Both genes are induced by
various environmental stresses [26].
The increases in expression of some of the genes in group II
occurred more slowly. This was the case for Nrgn (neurogra-
nin), Ncdn (neurochondrin), Camk2b (calcium/calmodulin-
dependent protein kinase II, β subunit), and Nptxr (neuronal
pentraxin receptor). Many of these genes encode proteins
related to calcium-mediated signaling, such as regulation of the
Ca2+- and Ca2+/calmodulin-dependent signaling pathway [27].
The increases in the expression of these genes may point to the
importance of Ca2+ regulation and of pathways controlled by
intracellular Ca2+ in the defense of cells against stimuli initiated
by OS.
Another gene whose expression was induced during the
period of OS was Slc17a6 (vesicular glutamate transporter 2 or
Vglut2) (Table 1). The up-regulation of Slc17a6 expression
under conditions of OS may be a sign of increases in progenitor
cell differentiation to mature neurons [28] rather than increases
in excitability within the hippocampus. Finally, some of the
group II genes showed more complex patterns of up-regulation
in both CA1 and CA3. Expression of these genes was elevated
within 0.5 h after the initiation of exposure to DQ, followed by a
decrease between 0.5 and 3 h and a subsequent second wave of
increase. Rgs4 (regulator of G-protein signaling 4), Rgs7, and
Drd1ip (dopamine receptor D1-interacting protein) had such
patterns of expression. Rgs4 and Rgs7 are predominantly
expressed in brain [29,30], are capable of binding to Gα
subunits, can deactivate Gα, and terminate downstream signals
[31,32], thus protecting neurons from ROS-induced activation
of Gα [33,34]. Nonmonotonic expression profiles for genes
such as Egr1 (early growth response-1) have been observed
under other stress conditions, e.g., in hypoxia [35]. We speculate
Table 2
GO terms significantly associated with genes that show similar patterns of
expression during OS in neurons of CA1 and CA3
GO terms a Total
number
Observed
number
Expected
value b
Corrected
p value c
GO terms significantly associated with down-regulated genes
Signal transduction and transport
Cell surface receptor-linked
signal transduction (BP)
112 2 0.16 3.52×10–4
Signal transduction (BP) 646 2 0.94 0.010
Kinase activity (MF) 408 2 0.59 0.013
Transport (BP) 832 2 1.21 0.017
Receptor activity (MF) 757 2 1.02 0.039
Immune response (BP) 174 5 0.25 5.35×10–7
GO terms significantly associated with up-regulated genes
Signal transduction
Activation of MAPKKK(BP) 3 2 0.01 4.05×10–7
Negative regulation of
protein kinase activity (BP)
20 2 0.07 1.58×10–4
Regulation of GPCR protein
signaling pathway (BP)
25 2 0.09 2.10×10–4
Calmodulin binding (MF) 111 3 0.38 0.002
Synaptic transmission (BP) 231 3 0.79 0.005
Cell–cell signaling (BP) 171 2 0.58 0.009
Signal transduction (BP) 646 5 2.21 0.010
Heterotrimeric G-protein
complex (CC)
38 2 0.13 0.016
Intracellular signaling
cascade (BP)
295 2 1.01 0.026
Stress response
Response to stress (BP) 69 2 0.24 0.002
DNA repair (BP) 87 2 0.30 0.003
Apoptosis
Antiapoptosis (BP) 86 2 0.29 0.003
Apoptosis (BP) 213 2 0.73 0.014
Neurogenesis
Neuron differentiation (BP) 23 2 0.08 2.28×10–4
Neurogenesis (BP) 259 3 0.89 0.006
a The Gene Ontology (GO) database used for the analysis was that of July
2006.
b The expected value was calculated as ((total number of differentially
expressed genes×total number of genes in each GO term)/total number of genes
in the whole gene array).
c The corrected p value is an indicator of statistical significance of the change
in each GO term. The values shown were obtained after false discovery rate
multiple test correction.
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as genes that respond to early stress and as genes involved in cell
repair at a later stage (i.e., 12 h).
To ascertain the cellular or biological functions of the genes
that had common response patterns in neurons of the CA1 and
CA3, Gene Ontology (GO) analyses were performed. By using a
controlled vocabulary to describe gene and protein attributes, the
GO project assigns genes and their products into relevant GO
categories in terms of their molecular functions (MF), involve-
ment in biological processes (BP), and associated cellular
components (CC). GO analysis of identified genes is an
important approach to uncovering functional profiles of
ensembles of genes [36]. We used a statistical test based on
the hypergeometric distribution implemented in Onto-Express
[37,38] to detect functional categories significantly altered by
OS. Based on the presence or absence of the identified genes
within each GO term, a p value was first calculated for each GO
term. The p values were further processed by multiple-test
correction [39] to control the false discovery rate effectively and,
as a result, generate a closer estimation of statistical significance
for each GO term. Table 2 presents the GO terms that had a
corrected p value less than 0.05 and contained at least two of the
identified genes.
The results of the GO analyses revealed several functional
categories of genes whose expression was altered in a similar
manner in CA1 and CA3 following exposure to OS. These
categories were: (i) signal transduction, (ii) stress response, (iii)
apoptosis, and (iv) neurogenesis. A large number of genes were
associated with signal transduction, including both intercellular
and intracellular signaling. Some signal transduction genes went
up, while others went down, during the period of OS. Expression
of genes in the categories of synaptic transmission, calmodulin
binding, and G-protein-coupled receptor (GPCR) signaling was
up-regulated during OS treatment. Heightened OS led to
increases in expression of genes related to cell stress responses
in neurons of both CA1 and CA3. The GO categories “response
to stress” and “DNA repair” were enriched with genes whose
expression was increased during OS. On the other hand, the
expression of some genes related to immune responses was
decreased in both CA1 and CA3. For example, expression of
chemokine genes Ccl6 (chemokine C–C motif ligand 6) and
Cxcl4 (chemokine C–X–C motif ligand 4 or platelet factor 4)
was decreased during most of the period of OS. The changes in
expression of these genes differed from those of other
chemokine and cytokine genes that were strongly up-regulated
across time in CA1 (Table 3).
Although CA1 neurons died to a much greater extent than
CA3 neurons following exposure to DQ, up-regulation of genes
related to apoptosis and antiapoptosis occurred in both CA1 and
CA3 cells. These results were an indication that pathways other
than those subserved by this group of genes might have been
responsible for the differential cell death of CA1 neurons. The
last GO category enriched with genes up-regulated in both CA1
and CA3 was that of neurogenesis. The enrichment of this
category of genes may be a reflection of attempts by CA1 and
CA3 neurons to activate repair processes, replace lost neurons,
or regrow neurites.Biological pathway analysis was also conducted to uncover
functional profiles of the DQ-responsive genes whose expres-
sion is up- or down-regulated in both CA1 and CA3. The
Biological Pathway approach assembles genes (or correspond-
ing proteins) with different functions into a biologically
meaningful framework needed for a certain biological task or
process. The pathway databases on which we based our
analyses were those covered by the Kyoto Encyclopedia of
Genes and Genomes [40], BioCarta, and GenMAPP [41]. We
identified the calcium signaling pathway as one that was
significantly enriched with both up-regulated (p=0.031, after
multiple test correction) and down-regulated genes (p=0.027)
in both CA1 and CA3. This may indicate that neurons in both
regions were attempting to control signal transduction mediated
Table 3
Currently known genes showing differential expression patterns between CA1
and CA3 following OS
Affx_ID Gene symbol Description Rank a
Genes whose expression was consistently higher in CA1
1370956_at Dcn Decorin 1
1370228_at Tf Transferrin 3
1387011_at Lcn2 Lipocalin 2 19
1367973_at Ccl2 Chemokine (C–C motif) ligand 2 21
1387316_at Cxcl1 Chemokine (C–X–C motif) ligand 1 28
1368420_at Cp Ceruloplasmin 29
1370432_at Pou3f1 POU domain, class 3,
transcription factor 1
41
1368760_at Cxcl2 Chemokine (C–X–C motif) ligand 2 42
1370201_at Calb1 Calbindin 1 46
1368224_at Serpina3n Serine (or cysteine) peptidase inhibitor,
clade A, member 3N
48
1369644_at Lphn2 Latrophilin 2 50
1387068_at Arc Activity regulated
cytoskeletal-associated protein
52
1387659_at Gda Guanine deaminase 54
1375877_at Syt4 Synaptotagmin IV 57
1387291_at Itih3 Inter-α-trypsin inhibitor, heavy chain 3 63
1387995_a_at Ifitm3 Interferon induced
transmembrane protein 3
65
1367577_at Hspb1 heat shock 27kDa protein 1 66
1390112_at Efemp1 Epidermal growth factor-containing
fibulin-like extracellular matrix
protein 1
74
1377340_at Tfpi2 Tissue factor pathway inhibitor 2 87
1372294_at Perc64 PE responsive protein c64 (peroxidase
and cell adhesion domains)
88
1388138_at Thbs4 Thrombospondin 4 97
Genes whose expression was consistently higher in CA3
1367749_at Lum Lumican 9
1368990_at Cyp1b1 Cytochrome P450, family 1,
subfamily b, polypeptide 1
15
1374787_at Kcnf1 Potassium voltage-gated channel,
subfamily F, member 1
16
1379747_at Prss35 Protease, serine, 35 17
1368114_at Fgf13 Fibroblast growth factor 13 23
1390358_at Cacna2d3 Calcium channel, voltage dependent,
alpha2/gamma subunit 3
27
1370058_at Nefl Neurofilament, light polypeptide 32
1370059_at 92
1368861_a_at Mag Myelin-associated glycoprotein 34
1371057_at Gabra5 Gamma-aminobutyric acid (GABA-A)
receptor, subunit α5
37
1372953_at Ncald Neurocalcin δ 39
1368523_at Cadps Ca2+-dependent secretion activator 45
1373646_at Rab15 RAB15, member RAS oncogene family 59
1368810_a_at Mbp Myelin basic protein 64
1376895_at Il16 Interleukin 16 (mapped) 70
1369670_at Cd200 Cd200 antigen 91
1387961_at Opcml Opioid-binding protein/cell adhesion
molecule-like
93
1386943_at Pllp Plasma membrane proteolipid 95
a Based on time-course expression difference detected by timecourse R
package.
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pathway involved in signal transduction, the MAPK signaling
pathway, was also found to be significantly enriched with genes
whose expression was up-regulated in both CA1 and CA3neurons (p=0.040). These results were in agreement with those
of the GO analysis described above (Table 2).
Differences in gene transcription patterns between CA1 and
CA3 neurons during OS
Using the multivariate empirical Bayes model in the Time-
course package, we identified 97 genes (0.61% of the 15,866
probe sets) whose expression patterns diverged significantly
between CA1 and CA3 upon DQ treatment. The divergence in
expression of genes between CA1 and CA3 was determined
using the MB and T˜2 statistics-based ranking and visualization
offered by the Timecourse package. The expression patterns
were classified by hierarchical clustering (Fig. 2B). Based on
the clustering results, we grouped these genes into three
categories (Fig. 2B). The 27 genes in category I generally
showed higher expression in CA1 than in CA3 during DQ
treatment. The currently known genes in category I are listed in
Figs. 2B and 2C and Table 3. The 31 genes in category III were
expressed more highly in CA3 than in CA1 during DQ
treatment. The known genes in category III are also listed in
Table 3. The remaining genes belonged to category II, showing
different dynamic changes in response to DQ, but no consistent
pattern in one region vs the other (Fig. 2B).
Many of the category II genes showed triphasic dynamic
patterns of expression in CA1 neurons, with increases in
expression during 0 to 0.5 h, decreases between 0.5 and 3 h,
and subsequent increases during the period 3 to 12 h. In CA3,
the same genes either showed increased expression only in
the last period of treatment or were consistently increased
throughout the period of exposure to DQ. Several category II
genes were related to synaptic vesicle trafficking and docking,
processes involved in neurotransmitter release. These genes
encode SNARE proteins (soluble N-ethylmaleimide-sensitive
factor attachment protein receptors), such as SNAP25 (synap-
tosomal-associated protein, 25 kDa) and VAMP1 (vesicle-
associated membrane protein 1, or synaptobrevin 1), and
synaptic vesicle-associated proteins, such as CPLX1 (com-
plexin 1), SYN2 (synapsin II), and SYNGR1 (synaptogyrin 1).
SNAP25 is highly sensitive to ROS [42] and is a potential
presynaptic ROS sensor that mediates ROS-induced impair-
ment in neurotransmitter release. Up-regulation of SNAP25
transcription may reflect efforts of neurons to compensate for
the loss of its activity. The up-regulation of several of these
genes was more rapid in CA1 than in CA3 neurons (Fig. 2B).
The more rapid up-regulation of these genes in CA1 might
indicate that the presynaptic neurotransmitter releasing
machinery was affected to a greater degree in this vulnerable
region.
The patterns of regional expression of some of the identified
genes, e.g., Pou3f1, Lphn2 (both higher in CA1; Fig. 2C and
Table 3), and Nefl (higher in CA3; Table 3), were in agreement
with previously reported mRNA and protein expression levels
in hippocampal regions determined by either in situ hybridiza-
tion or immunostaining. POU3F1 protein is expressed in CA1 at
higher levels than in CA3 [43]. This general pattern was
supported by our GeneChip data. The expression of the mRNA
207X. Wang et al. / Genomics 90 (2007) 201–212for the receptor for α-latrotoxin (latrophilin 2), Lphn2, is
confined to only the CA1 region of the hippocampus [44]. By
GeneChip analysis, we found that this gene was expressed in
CA1 at a significantly higher level than in CA3. On the other
hand, neurofilament light polypeptide, Nefl, is more abundant
in CA3 than in CA1 [45], which was also found to be the case in
the present study. The similar patterns of expression in CA1 and
CA3 detected in previous studies using various experimental
techniques and in the present study by GeneChip analysis
provided partial confirmation of the validity of the results
obtained by the microarray analysis.
Among the genes showing overall higher expression in CA1
than in CA3 were several immune response genes, Cxcl1 and
Cxcl2, and Ifitm3 (Table 3 and Fig. 2C). Cxcl1 (also known
as Gro1) is a gene that stimulates growth of some tumor cells
and has an important function in inflammation and wound
healing [46]. Another gene whose expression was differentially
increased in CA1 over CA3 neurons was Tfpi2 (tissue factor
pathway inhibitor 2). Expression of Tfpi2 is increased during
acute inflammatory responses [47]; therefore, this gene may be
involved in anti-inflammatory responses in cells of the CA1.
Added to the list of genes whose expression is increased during
inflammation and whose function is to suppress inflammatory
responses is the gene Serpina3n (serine peptidase inhibitor,
clade A, member 3N, or α1-anti-chymotrypsin) [48]. Serpina3n
expression was higher in CA1 than in CA3 neurons before and
during DQ treatment. SERPINA3 forms part of the inflamma-
tory response in neurodegenerative diseases [48]. Increases in
expression of these genes in CA1 might be indicative of higher
activation of wound healing or recovery from trauma in cells of
this brain region. This would be consistent with the differential
increases in expression of other genes involved in antioxidant
and anti-inflammatory defenses in cells of the CA1 region
described below.
The higher levels of expression in CA1 over CA3 neurons of
Tf (transferrin) and Cp (ceruloplasmin) before and during the
period of OS fit well with our previous observation that CA1
neurons, in the absence of any exogenously induced OS, express
higher levels of these two genes [4]. Both proteins are involved
in metal transport and are part of either pro- or antioxidant
processes in cells [49]. Ceruloplasmin is a ferroxidase [50] and
functions as an antioxidant protein during inflammation or
hyperoxia [51]. Another gene that codes for a protein that
sequesters iron is Lcn2 (lipocalin2) [52]. Expression of this gene
was also higher in CA1 than in CA3 cells during OS. This gene
has not been previously linked to neuronal stress or damage.
Thus, transport, sequestration, and oxidation of iron and copper
appeared to be primary functions of genes that were consistently
higher in CA1 than in CA3 before and during OS.
Hspb1 (heat shock protein 27 or Hsp27) also had higher
levels of expression in CA1 over CA3 cells before, during, and
after induction of OS. HSP27 is a microtubule-interacting, heat
shock protein that protects a variety of cells, including neuronal
cells, from stress stimuli that lead to apoptosis [53,54]. HSP27
decreases ROS production in cells that overexpress the mutated
Huntington disease protein and protects these cells from OS-
induced cell death [55]. The high levels of expression of Hspb1by CA1 neurons might be viewed as part of a coordinated
attempt to overcome the damaging effects of OS. Other notable
genes whose expression was higher in CA1 compared with CA3
neurons were Arc, Calb1, Gda, Thbs4, and Syt4 (Table 3). Arc
(activity-related cytoskeletal-associated protein) is a neuronal
immediate early gene whose expression is rapidly and tran-
siently increased in the hippocampus CA1 region upon synaptic
activation of pyramidal neurons [56] or following electrocon-
vulsive stimulation of the cortex [57]. In this study, expression
of Arc in the CA1 and CA3 regions increased rapidly (at 0.5 h)
and continued to increase to a significantly higher level in CA1
than in CA3 at 12 h.
A gene whose expression is highly correlated with resistance
of hippocampus and dentate gyrus neurons to various types of
stresses, including ischemia and epileptic seizures, is Calb1
(calbindin-D28K). The differential regulation between CA1 and
CA3 of Gda (guanosine deaminase or Cypin or p51-nedasin),
the gene for a protein that increases dendrite branching in
neurons [58], might be another indicator of attempts by neurons
of the CA1 region to overcome the damaging effects of OS and
reestablish normal synaptic activity. This interpretation is
supported by the selective induction in CA1 of the genes for
two other proteins that promote neurite outgrowth and local
synapse differentiation, Thbs4 (thrombospondin 4) [59] and
Syt4 (synaptotagmin 4) [60] (Fig. 2C and Table 3).
It is also important to note that proteins such as GDAmay act
in the formation of synapses, especially the postsynaptic
structures. GDA interacts with PDZ domain-containing proteins
at postsynaptic sites of excitatory synapses [61]. Another protein
that interacts with PDZ domain-containing proteins is that
encoded by the gene Lphn2, a protein that is almost exclusively
expressed in CA1 [44] and whose expression is differentially
increased in CA1 by DQ treatment (Table 3).
Only one gene that falls in the general functional category of
a stress-response gene was expressed at higher levels in CA3
than in CA1 cells during OS. This gene was Il16 (interleukin
16). There was, however, higher expression in CA3 than in CA1
of Gabra5 (GABA receptor α5). Increases in the activity of the
inhibitory neurotransmitter γ-aminobutyric acid (GABA)
would be expected to decrease neuronal excitation and thus
may lead to some level of protection of neurons in the CA3
region against any excitatory effects induced by OS.
The results of GO analyses of the genes in categories I and III
are summarized in Table 4. The GO analysis indicated a higher
level of up-regulation of transcription in CA1 than in CA3
neurons of genes related to stress responses, including
chemokine, cytokine, and inflammatory response genes. This
finding is further supported by our analysis of biological
pathways that identified the cytokine–cytokine receptor inter-
action pathway as the only one having reached statistical
significance (corrected p=0.0019). Many of the genes shown in
Table 3 and discussed above were included in the GO category
and Biological Pathway described as stress-response genes. The
GO analyses also identified the categories of genes related to
synaptic vesicle transport and neurotransmitter release and of
GPCRs as being more highly expressed following OS in CA1
compared with CA3 (Table 4). Although expression of genes in
Table 4
Comparison of Gene Ontology (GO) categories associated with genes expressed
at higher levels in CA1 over CA3, or the reverse
GO terms a Total
number
Observed
number
Expected
value b
Corrected
p value c
GO terms significantly associated with CA1-higher genes
Stress response
Chemokine activity (MF) 21 3 0.04 5.31×10–7
Cytokine activity (MF) 83 3 0.14 6.07×10–5
Inflammatory response (BP) 115 3 0.20 1.10×10–4
Response to unfolded
protein (BP)
37 1 0.06 0.001
Transition metal activity
Ferroxidase activity (MF) 2 1 <0.01 1.89×10–5
Iron ion homeostasis (BP) 15 2 0.03 2.68×10–5
Copper ion homeostasis (BP) 5 1 0.01 8.37×10–5
Ferric iron binding (MF) 5 1 0.01 1.26×10–4
Copper ion transport (BP) 11 1 0.02 2.42×10–4
Iron ion transport (BP) 14 1 0.02 3.09×10–4
Synaptic vesicle transport and neurotransmitter secretion
Synaptic vesicle transport (BP) 11 1 0.02 2.57×10–4
Calcium ion-dependent
exocytosis (BP)
15 1 0.03 3.40×10–4
Synaptic vesicle (CC) 67 1 0.11 5.15×10–4
Neurotransmitter
secretion (BP)
33 1 0.06 0.001
GPCR activity
GPCR protein signaling
pathway (BP)
355 2 0.61 0.006
GPCR activity (MF) 254 1 0.43 0.044
GO terms significantly associated with CA3-higher genes
GABA activity
GABA signaling pathway (BP) 22 1 0.04 0.002
GABA-A receptor activity (MF) 33 1 0.06 0.006
Calcium channel (voltage-gated) activity
Voltage-gated calcium
channel activity (MF)
32 1 0.06 0.006
Calcium ion transport (BP) 92 1 0.18 0.011
Voltage-gated calcium
channel complex (CC)
33 1 0.06 0.019
Potassium channel (voltage-gated) activity
Voltage-gated potassium
channel activity (MF)
64 1 0.13 0.011
Potassium ion transport (BP) 145 1 0.28 0.020
Voltage-gated potassium
channel complex (CC)
66 1 0.13 0.033
Postsynaptic activity
Neurotransmitter receptor
activity (MF)
45 1 0.09 0.008
Synaptic transmission (BP) 231 2 0.45 0.009
Postsynaptic membrane (CC) 69 1 0.14 0.025
a The GO database used for the analysis was that of July 2006.
b The expected value was calculated as described for Table 2.
c The corrected p value is defined in Table 2.
Fig. 3. Correlation of GeneChip and real-time qPCR data. The expression ratios
between CA1 and CA3 for five genes, Junb, Mt1a, Nqo1, Nfe2l2, and Tf,
estimated by qPCR were plotted against those estimated by GeneChip
microarray analyses. The points represent the ratios estimated at four time
points. Three qPCR replicate measurements were made for each gene at each of
the four time points, i.e., each data point represents the mean of three
measurements. The expression ratios shown represent the means of the ratios
from the replicate determinations. The median standard error was 0.55 for
GeneChip and 0.69 for qPCR. The Pearson correlation coefficient (r) between
GeneChip and qPCR data and the estimated p value are shown at the bottom.
The best-fit linear regression line (solid line) and the estimated 95% confidence
limits (dashed lines) are also shown.
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significantly higher in CA1 than CA3, there was only one
gene in each of these categories whose expression was higher.
The CA3 region had statistically higher expression than CA1
in GO categories related to postsynaptic activity, GABA
activity, and voltage-gated calcium and potassium transport
(Table 4). Although expression of genes in the various GO
categories under GABA activity and voltage-gated calcium and
potassium transport was significantly higher in CA3 than inCA1, there was only one gene in each of these categories whose
expression was higher.
Confirmation of the microarray gene expression patterns using
real-time PCR (qPCR)
For the qPCR studies, we selected five genes that are known
to be involved in antioxidant responses in cells: Junb, Mt1a
(metallothionein 1A),Nqo1 (NAD(P)H:quinone oxidoreductase
1), Nfe2l2 (NF-E2-related factor-2), and Tf. The selection of
these genes was based also on their differential expression in
CA1 vs CA3. Although the expression patterns of these genes
(except Tf) did not reach statistical significance of differential
expression in CA1 vs CA3 according to the Timecourse
package, all five genes showed higher expression in CA1 than
in CA3 for all time points. There was a significant correlation
between the microarray data and the qPCR results for all five
genes (Fig. 3). The estimated Pearson product-moment correla-
tion coefficient was highly significant (Fig. 3). The standard
error of bothmethods was comparable: themedian for GeneChip
was 0.55 (range: 0.03–2.17), while the median for qPCR was
0.69 (range: 0.04–3.63). These results, along with the high
reproducibility of the GeneChip data, confirmed the validity of
the data gathered by the GeneChip microarray method.
Molecular confirmation of the induction of OS based on the
levels for JUNB and SQSTM1
Two proteins whose levels in neurons are known to be
rapidly altered by a variety of stresses, especially OS, are JUNB
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chosen to confirm at the molecular level the induction of OS in
hippocampus. Junb mRNA and protein levels are increased
following traumatic brain injury or chemically induced OS
[62,63]. Sqstm1 expression increases in response to a variety of
stress conditions, including OS [64,65]. In the GeneChip
analyses, we found that the transcripts of Junb, in both CA1 and
CA3, increased rapidly (within 0.5 h) after exposure of the
slices to DQ and then gradually returned toward baseline levels
at 12 h. The protein level of JUNB, as detected by immunoblots,
showed a continuous increase throughout the period of OS in
both CA1 and CA3, with the correlation coefficients (r)
between JUNB level and elapsed time being 0.89 in CA1 and
0.95 in CA3. Also, there was a high degree of correlation
between the JUNB levels in CA1 and those in CA3 across all
time points (r=0.97; p=0.034).
For Sqstm1, mRNA levels also showed a rapid increase,
in both CA1 and CA3, within 0.5 h after DQ exposure,
followed by slow but continuous further increases in Sqstm1.
Estimated coefficient for interregion (CA1 vs CA3) correla-
tion was r=0.99 (p=0.003). The protein level of SQSTM1
also increased quickly after initiation of OS and continued to
rise up to 3 h. The levels of SQSTM1 were highly correlated
between CA1 and CA3 (r=0.98, p=0.022). The GeneChip and
Western blot results for Junb and Sqstm1 expression described
above were a strong indication that OS was indeed established
in hippocampus slices exposed to DQ. Completely identical
patterns for mRNA and protein changes across time of ex-
posure to DQ were not expected, as changes in mRNA levels
would normally precede those in protein levels.
Concluding remarks
To begin to identify molecular mechanisms for the selective
vulnerability of CA1 neurons to OS, a multiple-time-point
dynamic transcriptome analysis was employed in the assessment
of time-dependent changes in neuronal injury induced by OS.
Functional genomic analyses were used to compare genome-
wide gene expression responses to increased OS in a vulnerable,
CA1, and a resistant, CA3, region of the hippocampus. The
clearest difference between these two regions in terms of their
OS responses was the much higher level of induction of genes
related to stress and anti-inflammation in CA1 compared with
CA3. Such differential induction might be an indication that
CA1 neurons are endogenously, and possibly continuously,
under higher stress than CA3 neurons. A state of high endo-
genous stress in CA1 neurons, we hypothesize, may predispose
them to cell damage and loss of viability when confronted with
further increases in OS. Several genes that either have not been
previously linked to neuronal responses to stress or have not
been considered as part of the gene expression repertoire in
response to OS, such as Gda, Lcn2, Lphn2, and Syt4, were
identified as ones that were differentially expressed in CA1
following the induction of OS. The genes identified in the
present study offer potential new targets for future experimental
manipulations to assess how their expression alters the
sensitivity of neurons to OS. In addition, the GO categoriesidentified in this study provide potential new molecular and
cellular pathways that can be probed for the causes of differential
neuronal vulnerability to OS or other forms of stress.
Experimental methods
Establishment of organotypic hippocampus cultures
Organotypic hippocampal slice cultures were established from male
Sprague–Dawley rat pups [4,14]. All animal procedures were performed in
accordance with the guidelines of the University of Kansas IACUC. Ten-day-old
male rat pups were anesthetized, the hippocampi dissected out, and slices
(300 μm) prepared using a McIlwain tissue chopper. The slices, maintained
briefly in ice-cold artificial cerebrospinal fluid (in mM: 124 NaCl, 2.8 KCl,
2 CaCl2, 2 MgSO4, 26 NaHCO3, 1.25 NaH2PO4, 10 glucose, pH 7.4), were
transferred onto BDTM Falcon Cell Culture Inserts (0.4 μm). The inserts were
positioned on the surface of cell culture medium consisting of 50% minimum
essential medium (Sigma–Aldrich, St. Louis, MO, USA), 25% Hanks’ balanced
salt solution, and 25% heat-inactivated horse serum (Invitrogen, Carlsbad, CA,
USA) in a solution containing 4.5 mg/ml glucose, 1 mM glutamine, and 20 ml/L
penicillin–streptomycin. The medium was changed every third day.
Induction of OS in cultures
To induce OS, the slices were treated with DQ [5]. The culture medium was
changed to serum-free medium 24 h prior to the initiation of DQ treatment. An
aliquot of DQ (100 mM stock solution) was added to the medium (final
concentration 100 μM). The duration of DQ treatment was 3 h. At the end of the
treatment period, the medium was removed and replaced with serum-free
medium. At 0.5, 3, 12, and 24 h after the initiation of DQ treatment, the slices
were rinsed three times with the same medium and stained with propidium
iodide (PI; 5 μg/ml) to determine cell death [5].
Microdissection of CA1 and CA3 pyramidal cell layer and isolation of
total RNA
Slice cultures not stained with PI along with the polyethylene terephthalate
matrix at the bottom of the inserts were detached from the plastic frame, fixed,
and stained using the HistoGene LCM Staining Kit (Arcturus, Mountain View,
CA, USA). Dissection of the pyramidal cell layers of CA1 and CA3 was
performed under a dissection microscope with tungsten needles, miniscalpels,
and microforceps. The dissections were performed at 0 h (no treatment with DQ)
and 0.5, 3, and 12 h post-exposure to DQ. The microdissected layers were
immersed in 350 μl RLT lysis buffer in the RNeasy Mini Kit (Qiagen, Valencia,
CA, USA), incubated for 30 min at 42°C, and centrifuged at 5400g for 2 min,
and total RNAwas extracted from the supernatant according to the protocol of
the Qiagen RNeasy Mini Kit.
Oligonucleotide microarray hybridization, data collection, and
analysis
Four cultures from four rat littermates under each condition of treatment with
DQ were used. The four replicates of mRNA were subjected to Affymetrix
GeneChip (Affymetrix, Santa Clara, CA, USA) analyses. The amount of total
RNA was in the range of 10–100 ng and the GeneChip Two-Cycle cDNA
Synthesis Kit (Affymetrix) was used for target preparation. The volume of the
isolated RNA was first concentrated to 7 μl in an Eppendorf Vacufuge
concentrator (Brinkmann Instruments, Westbury, NY, USA) and 3.5 μl was used
for two cycles of reverse and in vitro transcription. Affymetrix Rat Expression
230A (RAE230A) oligonucleotide arrays containing 15,866 probe sets and
interrogating 14,280 UniGene clusters, were used for hybridization (45°C for
16 h) with a mixture of 15 μg of fragmented cRNA. Three RNA samples
extracted from slices of two animals failed to produce enough quantity and
quality of cRNA after the amplification process. GeneChip data generated from
these were not subjected to further analyses. Subsequent washing and staining
steps were performed on a GeneChip Fluidics Station 400 and the chips were
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data collection were carried out using GeneChip Operating Software (GCOS
version 1.1.1). To minimize experimental variability, all steps in slice culture
preparation, DQ treatment, microdissection, RNA isolation, and microarray
operation were performed by a single investigator. The quality and quantity of
the RNA samples and of the cRNA probes were determined with a Bioanalyzer
2100 using the RNA 6000 Pico LabChip (Agilent Technologies, Palo Alto, CA,
USA), and by spectrophotometric measurements at 260 and 280 nm on
GeneQuant (Amersham Biosciences, Piscataway, NJ, USA). The microarray
data from all chips met the quality control criteria set by Affymetrix, including
low background and noise, positive detection of QC probe sets such as bioB,
percentage of genes called present in normal range (between 40 and 60%),
similar scaling factors across all chips, and 3′/5′ ratio.
For data analysis, the GCOS.cel data files were first preprocessed with
the RMA method by employing the rma function in the BioConductor
package Affy (version 1.8.1). This preprocessing step included (1) model-
based probe-specific correction of PM probes, (2) quantile normalization of
the corrected PM probes, and (3) median-polish-based calculation of
expression measure. The preprocessed data were used to calculate correlation
coefficients between replicate samples to evaluate array data reproducibility.
For this calculation, the preprocessed data of all probe sets were imported to
Microsoft Excel and Pearson correlation coefficients were calculated using
the CORREL function.
To identify genes showing convergent and divergent expression patterns
during OS treatment of the two hippocampal regions, the preprocessed data for
all probe sets were imported into the BioConductor package Timecourse
(version 1.2.1). This package offers a comprehensive library of functions for the
analysis of microarray time-course data. With this package, genes were ranked
based onMB and T˜2 statistics calculated from their overall dynamic expression
profiles [16]. Since no p values were provided by this package, genes of interest
were identified by the ranking and visualization of corresponding dynamic
expression profiles. Genes that had a fold-difference cutoff of 2.0 were called
up- or down-regulated in one region vs the other.
Hierarchical clustering (or gene tree) of both convergent and divergent genes
was conducted in GeneSpring GX (version 7.3). All gene RMA logarithmic
values were transformed to linear scale and mean-centered to 1.0 after importing
into GeneSpring. The similarity measure used was the Pearson correlation.
All gene expression data were deposited in NCBI’s Gene Expression
Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/). They are accessible
through GEO Series Accession No. GSE6693.
Gene ontology and biological pathway analyses
The 77 convergent and 97 divergent genes between CA1 and CA3,
identified by the above steps, were used for GO and Biological Pathway
analyses. Convergent genes were further separated into two groups, i.e., up- and
down-regulated genes (genes marked I and II in Fig. 2A). Divergent or
differentially expressed genes formed groups I and III of Fig. 2B. The complete
gene lists are presented in the online supplement. For GO analysis, individual
lists of genes were fed into Onto-Express (http://vortex.cs.wayne.edu/projects.
htm#Onto-Express) [37,38] and hypergeometric distribution and false discovery
rate corrections were set. For pathway analysis, the same gene lists were intro-
duced into Pathway-Express (http://vortex.cs.wayne.edu/projects.htm#Pathway-
Express) [66], hypergeometric distribution and false discovery rate corrections
were used, and other parameters were set at default values. The GO and
Biological Pathway databases used for the analyses were those of July 2006. A p
value of less than 0.05 after correction was considered significant.
Real-time qPCR
The remainder of the concentrated total RNA extracts from CA1 and CA3
not used for microarray analyses was used for qPCR (SmartCycler; Cepheid,
Sunnyvale, CA, USA). The RNAwas reverse-transcribed to cDNA using oligo
(dT) primers and TaqMan Gene Expression Assay reagents (Applied
Biosystems, Foster City, CA, USA) used for qPCR assays. The thermal cycling
conditions were 2 min at 50°C, 10 min at 95°C, and 45 cycles of 95°C for 15 s
and 60°C for 1 min. Quantification of target genes was based on the relative
standard curve [67].SDS–PAGE and immunoblot studies of JUNB and SQSTM1
Protein samples extracted from CA1 and CA3 of slice cultures were
subjected to SDS–PAGE and immunoblot analyses [68] using the Pierce
SuperSignal West Femto kit for protein immunolabeling. Polyclonal antibodies
for JUNB and SQSTM1were from Santa Cruz Biotechnologies, that for neuron-
specific enolase was from Chemicon. The amount of JUNB and SQSTM1 in
each extract was normalized against the densitometric value of the immuno-
labeled band of neuron-specific enolase. Enolase gene expression was not
altered following exposure of slices to OS, thus this protein was used as the
normalization standard.Acknowledgments
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